Figure 2: Cumulative number of antibody therapeutics approved by US and European Agency. Adapted from: Kaplon H, Reichert JM: Antibodies to watch in 2021. mAbs, 2022; 13: 1860476[7].
![Figure 2: Cumulative number of antibody therapeutics approved by US and European Agency. Adapted from: Kaplon H, Reichert JM: Antibodies to watch in 2021. <i>mAbs</i>, 2022; 13: 1860476<sup>[7]</sup>.](articles/2022/36/4/images/TaiwanJPsychiatry_2022_36_4_148_365329_f2.jpg)
| Close | |
|
|
|
|
Figure 2: Cumulative number of antibody therapeutics approved by US and European Agency. Adapted from: Kaplon H, Reichert JM: Antibodies to watch in 2021. mAbs, 2022; 13: 1860476[7].
|
|